NEW YORK (GenomeWeb News) – The American Medical Association and McKesson announced a licensing deal today to create a reference product for identifying and tracking molecular diagnostic tests.

The deal calls for McKesson Z-Code Identifiers to be grouped and indexed with corresponding molecular pathology codes in the AMA's Current Procedural Terminology code set. With the resulting reference product, "the healthcare industry can better understand the growth in this area to support advanced diagnostics innovation," AMA and McKesson said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.